University of Dundee Spinout Amphista Therapeutics Reaches Major Milestone as First Patient is Dosed With Their Frontline Degrader Drug
October 29, 2026
October 29, 2026
DUNDEE, Scotland, Oct. 29 -- The University of Dundee issued the following news release:
* * *
Dundee spinout Amphista therapeutics reaches major milestone as first patient is dosed with their frontline degrader drug
Fundamental research conducted in a University of Dundee laboratory that provided the basis for a novel protein degradation approach has paved the way for an new therapeutic candidate being tested in patients with acute myeloid leukaemia (AML). . . .
* * *
Dundee spinout Amphista therapeutics reaches major milestone as first patient is dosed with their frontline degrader drug
Fundamental research conducted in a University of Dundee laboratory that provided the basis for a novel protein degradation approach has paved the way for an new therapeutic candidate being tested in patients with acute myeloid leukaemia (AML). . . .
